Idera Pharmaceuticals, Inc. (IDRA) |
| 0.425 -0.127 (-23.04%) 01-17 16:00 |
| Open: | 0.4768 |
| High: | 0.51 |
| Low: | 0.4201 |
| Volume: | 371,878 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 16 |
| 52w Low: | 0.4201 |
Idera Pharmaceuticals, Inc. is a biopharmaceutical company committed to the research, development, and commercialization of medicines addressing rare diseases within the United States. A key offering is Tilsotolimod (IMO-2125), a proprietary synthetic phosphorothioate oligonucleotide. This compound functions as a direct TLR9 agonist, designed to stimulate the immune system to combat solid tumors, specifically targeting head and neck squamous cell carcinoma and colorectal cancer. The firm also holds a strategic collaboration agreement with Bristol-Myers Squibb. Founded in 1989, Idera Pharmaceuticals, Inc. is headquartered in Exton, Pennsylvania.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Wed, 28 Sep 2022
Idera Pharmaceuticals Acquires Aceragen - GlobeNewswire
Fri, 03 Jun 2022
Idera Pharmaceuticals Inc. (IDRA) Share Price Today | Idera Pharmaceuticals (IDRA) Live NSE/BSE - Value Research
Tue, 01 Dec 2020
Idera Pharmaceuticals Stock Price Forecast. Should You Buy IDRA? - StockInvest.us
Thu, 09 Nov 2017
Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More - 24/7 Wall St.
Fri, 27 Jan 2017
IDRA - Idera Pharmaceuticals Company Profile - StockInvest.us
Tue, 14 Jul 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
